Acrotech Biopharma
Subsidiary of Aurobindo Pharma (AUROPHARMA)
Assets
(3 total)
3Total Assets
3Approved
0Phase 3 / Filed
0Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | Histone Deacetylase InhibitorSmall molecule | Non-Hodgkin Lymphoma Peripheral T-Cell Lymphoma | |
difamilast(Moizerto / Adquey) | Approved | PDE4Small molecule | Atopic Dermatitis |
| Approved | DNA (guanine N7 position)Small molecule | Multiple Myeloma Autologous Stem Cell Conditioning in Multiple Myeloma |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Financial reports
No financial reports recorded.